Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
18 janv. 2018 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus,...
Clinical Genomics Pathology Inc. Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab
19 déc. 2017 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of liquid biopsy cancer testing solutions, today announced the Accreditation Committee of the College of...
Roy Davis Joins Liquid Biopsy Company Clinical Genomics Board of Directors
12 déc. 2017 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Roy Davis...
Clinical Genomics and Quest Diagnostics announce FDA 510(K) clearance of InSure® ONE™
13 nov. 2017 08h00 HE
|
Clinical Genomics
At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programs A number of...
Clinical Genomics Working with Leading Cancer Center to Evaluate Colvera™ in Patients with Colorectal Cancer
19 oct. 2017 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer testing solutions, today announced the initiation of a new rectal cancer therapy monitoring study...
QIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer
21 août 2017 16h10 HE
|
Clinical Genomics
HILDEN, Germany and GERMANTOWN, Md. and BRIDGEWATER, N.J., Aug. 21, 2017 (GLOBE NEWSWIRE) -- QIAGEN (NASDAQ:QGEN) (Frankfurt Prime Standard:QIA) and Clinical Genomics, a private company developing...
Data Presented at ASCO Annual 2017 Shows Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer
09 juin 2017 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., June 09, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, presented data demonstrating the utility of...
Clinical Genomics to Present Data at ASCO Supporting Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer
31 mai 2017 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., May 31, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, today announced that data demonstrating the...
Clinical Genomics Announces Participation in Fortified Provider Network and MultiPlan
08 mars 2017 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced it has signed agreements...
Clinical Genomics to Present Data at ASCO GI Supporting Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer
18 janv. 2017 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Jan. 18, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company marketing innovative diagnostic tools for colorectal cancer, today announced that data demonstrating the...